LGC acquires C/D/N Isotopes

News (ZH) - Acquisition of CDN strengthens LGC’s position in the deuterated compound market

LGC employing AccuPlex™ technology to develop quality control solutions in response to the coronavirus global health emergency

News (ZH) - Control material being produced in collaboration with several diagnostic manufacturers to support development, evaluation, and validation of molecular test methods

LGC expands production of AccuPlex™ COVID-19 reference materials to support global diagnostic assay development efforts

News (ZH) - Expansion of COVID-19 reference materials to include high titer stocks that serve as a valuable tool for diagnostic manufacturers

LGC expedites support to COVID-19 response efforts

News (ZH) - LGC is working closely with customers and other stakeholders to support the global response to the epidemic

LGC’s COVID-19 response

News (ZH) - LGC, an international leader in the life sciences tools sector, is playing an active role in the global response to COVID-19

LGC's innovative SARS-CoV-2 Quality Solutions now includes S gene

News (ZH) - Offers expanded genome coverage to include S gene region

LGC expands SARS-CoV-2 offering to include serology quality solutions

News (ZH) - Solutions address critical need for clinical laboratories to be able to report antibody testing results with confidence

LGC expands SARS-CoV-2 molecular solutions to full genome coverage

News (ZH) - Expansion allows for compatibility with any SARS-CoV-2 assay target, while maintaining safety features

LGC releases SARS-CoV-2 & influenza multiplexed molecular quality solutions

News (ZH) - Kit designed to measure day-to-day performance of the assay providing positive and negative reference solution